Seguir
Evgeny G Izumchenko
Evgeny G Izumchenko
Dirección de correo verificada de uchicago.edu - Página principal
Título
Citado por
Citado por
Año
Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare
P Mamoshina, L Ojomoko, Y Yanovich, A Ostrovski, A Botezatu, ...
Oncotarget 9 (5), 5665, 2018
4422018
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
R Ravi, KA Noonan, V Pham, R Bedi, A Zhavoronkov, IV Ozerov, ...
Nature communications 9 (1), 741, 2018
2862018
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, I Sloma, A Katz, D Vasquez-Dunddel, ...
Annals of Oncology 28 (10), 2595-2605, 2017
2722017
NEDD9 promotes oncogenic signaling in mammary tumor development
E Izumchenko, MK Singh, OV Plotnikova, N Tikhmyanova, JL Little, ...
Cancer research 69 (18), 7198-7206, 2009
1522009
The TGFβ–miR200–MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors
E Izumchenko, X Chang, C Michailidi, L Kagohara, R Ravi, K Paz, M Brait, ...
Cancer research 74 (14), 3995-4005, 2014
1502014
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
E Izumchenko, X Chang, M Brait, E Fertig, LT Kagohara, A Bedi, ...
Nature communications 6 (1), 8258, 2015
1492015
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
IV Ozerov, KV Lezhnina, E Izumchenko, AV Artemov, S Medintsev, ...
Nature communications 7 (1), 13427, 2016
1342016
Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia
H Sharabani, E Izumchenko, Q Wang, R Kreinin, M Steiner, Z Barvish, ...
International Journal of Cancer 118 (12), 3012-3021, 2006
1052006
Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization
F Cortese, D Klokov, A Osipov, J Stefaniak, A Moskalev, J Schastnaya, ...
Oncotarget 9 (18), 14692, 2018
922018
Notch1 mutations are drivers of oral tumorigenesis
E Izumchenko, K Sun, S Jones, M Brait, N Agrawal, W Koch, CL McCord, ...
Cancer prevention research 8 (4), 277-286, 2015
872015
Immune profiles in primary squamous cell carcinoma of the head and neck
V Saloura, E Izumchenko, Z Zuo, R Bao, M Korzinkin, I Ozerov, ...
Oral Oncology 96, 77-88, 2019
672019
Adenoid cystic carcinoma: emerging role of translocations and gene fusions
PT Wysocki, E Izumchenko, J Meir, PK Ha, D Sidransky, M Brait
Oncotarget 7 (40), 66239, 2016
672016
Patient‐derived xenografts as tools in pharmaceutical development
E Izumchenko, J Meir, A Bedi, PT Wysocki, MO Hoque, D Sidransky
Clinical Pharmacology & Therapeutics 99 (6), 612-621, 2016
672016
SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells
H Ozawa, RS Ranaweera, E Izumchenko, E Makarev, A Zhavoronkov, ...
Clinical Cancer Research 23 (17), 5162-5175, 2017
662017
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use
C Michailidi, M Hayashi, S Datta, T Sen, K Zenner, O Oladeru, M Brait, ...
Cancer prevention research 8 (3), 208-221, 2015
602015
Integrated analysis of whole-genome ChIP-Seq and RNA-Seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks
DZ Kelley, EL Flam, E Izumchenko, LV Danilova, HA Wulf, T Guo, ...
Cancer research 77 (23), 6538-6550, 2017
572017
Cleaved NOTCH1 expression pattern in head and neck squamous cell carcinoma is associated with NOTCH1 mutation, HPV status, and high-risk features
EM Rettig, CH Chung, JA Bishop, JD Howard, R Sharma, RJ Li, ...
Cancer prevention research 8 (4), 287-295, 2015
562015
Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now?
HS Nam, E Izumchenko, S Dasgupta, MO Hoque
Biomarkers in medicine 11 (6), 475-489, 2017
542017
Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients
Q Zhu, E Izumchenko, AM Aliper, E Makarev, K Paz, AA Buzdin, ...
Human genome variation 2 (1), 1-9, 2015
522015
Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma
A Zhavoronkov, E Izumchenko, RR Kanherkar, M Teka, C Cantor, ...
Cell Cycle 15 (12), 1643-1652, 2016
512016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20